37Q-19136-02427
2 vaccinations
2 coded responses
10 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 232 / VA
- Registered
- 2020-12-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-15
Dose 1 — Pfizer-BioNTech
-
2020-12-16
Registered in v-safe
- 2020-12-16
- 2020-12-17
- 2020-12-19
- 2020-12-20
- 2020-12-21
-
2021-01-04
Dose 2 — Pfizer-BioNTech
-
2021-01-07
Survey response — days 1–6 daily, dose 2MedDRA: Menstruation irregular — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, DiarrheaFree text: Menstrual cycle changesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-10
- 2021-01-18
-
2021-04-05
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-15 | Pfizer-BioNTech | |
| 2 | 2021-01-04 | Pfizer-BioNTech |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Menstrual cycle changes
Release 6 — 3 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SRO | Menstruation irregular | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release